| Literature DB >> 34764312 |
Faryal Batool1, Muhammad Shahid Iqbal2, Salah-Ud-Din Khan3, Javed Khan4, Bilal Ahmed5, Muhammad Imran Qadir6.
Abstract
Nanotechnology is a vast field of science with the most vibrant and conspicuous applications. The green synthesis approach is cost-effective, eco-friendly, and produces the most stable metal-based nanoparticles without the use of toxic chemicals. This study presents the green synthesis of iron nanoparticles (FeNPs). For biosynthesis of FeNPs, Phoenix dactylifera extract was used as a reducing agent and iron sulfate heptahydrate (FeSO4·7H2O) was used as a substrate. FeNPs were characterized by different techniques including UV-Visible spectroscopy, Fourier transform infrared spectroscopy (FTIR), and nano zeta-sizer analysis. The antimicrobial activity of FeNPs synthesized by using an aqueous extract of Phoenix dactylifera was evaluated against Escherichia coli, Bacillus subtilis, Micrococcus leutus, and Klebsiella pneumoniae. A notable color change from yellow to black confirmed the synthesis of FeNPs. The sharp peak at 450 nm UV-Visible spectroscopy confirmed the synthesis of FeNPs. FTIR showed the presence of O-H and C=C stretching due to the presence of phenol and alkene functional groups. The average size of FeNPs was 6092 d.nm. The results of antimicrobial activity showed that FeNPs exhibit different potential against different bacterial strains with a maximum 25 ± 0.360 zone of inhibition against Escherichia coli. Thus, green synthesized FeNPs could be used as potential antimicrobial agents.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34764312 PMCID: PMC8586337 DOI: 10.1038/s41598-021-01374-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Iron Nanoparticles synthesized by Phoenix dactylifera leaves extracts.
Figure 2UV absorbance spectrum for FeNPs synthesized by Phoenix dactylifera leaves extract.
Figure 3FTIR Spectrum for FeNPs synthesized by Phoenix dactylifera leaves extract.
Figure 4Size distribution by Intensity of FeNPs synthesized from Phoenix dactylifera leaves extract.
Zone of Inhibition of FeNPs synthesized by Phoenix dactylifera.
| Standard drug and Sample | Number of Replicates | ||||
|---|---|---|---|---|---|
| Standard drug (ciprofloxacin) | 1 | 37.8 | 36.7 | 35.2 | 37.9 |
| 2 | 38.2 | 36.4 | 36.6 | 37.8 | |
| 3 | 38 | 38 | 36.2 | 38.3 | |
| Mean ± SD | 38 ± 0.200 | 37 ± 0.850 | 36 ± 0.721 | 38 ± 0.264 | |
| Aqueous extract of | 1 | 12.0 | 10.0 | 10.0 | 13.2 |
| 2 | 11.0 | 10.0 | 10.0 | 10.8 | |
| 3 | 10.0 | 10.0 | 10.0 | 12.0 | |
| Mean ± SD | 11 ± 0.102 | 10 ± 0.250 | 10 ± 0.312 | 12 ± 0.140 | |
9 mM FeNPs | 1 | 12.8 | 13.8 | 0 | 13.4 |
| 2 | 13.4 | 14.2 | 0 | 12.5 | |
| 3 | 12.8 | 14 | 0 | 13.1 | |
| Mean ± SD | 13 ± 0.346 | 14 ± 0.200 | 0 ± 0 | 13 ± 0.458 | |
11 mM FeNPs | 1 | 19.6 | 23.2 | 16.4 | 21.6 |
| 2 | 19.3 | 22.5 | 17.7 | 22.3 | |
| 3 | 21.1 | 23.3 | 16.9 | 22.1 | |
| Mean ± SD | 20 ± 0.964 | 23 ± 0.435 | 17 ± 0.655 | 22 ± 0.360 | |
13 mM FeNPs | 1 | 22.7 | 24.9 | 18.8 | 25.7 |
| 2 | 23.2 | 25.4 | 19.4 | 24.8 | |
| 3 | 23.1 | 24.7 | 21.8 | 24.8 | |
| Mean ± SD | 23 ± 0.264 | 25 ± 0.360* | 20 ± 1.587 | 25 ± 0.519* |
*p value < 0.05 indicates significant results compared to standard.
Figure 5(A) Antimicrobial activity of synthesized FeNPs against (a) Bacillus subtilis, (b) Escherichia coli, (c) Micrococcus leutus, (d) Klebsiella pneumonia. (B) Antimicrobial activity of standard drug and extract of Phoenix dactylifera leaves against (a) Bacillus subtilis, (b) Escherichia coli, (c) Micrococcus leutus, (d) Klebsiella pneumonia.